Readers likely know by now how easy it is for this to happen, as we frequently report on retractions due to similar reasons. Like other instances of mistaken cell identity, the authors of this 2013 paper realized the mistake following further tests of the bacteria used in the experiment.
Authors have retracted a case report describing a surgery to remove gallstones in a patient with Crohn’s disease after learning they’d mixed up two cases, and instead reported on a patient who had died 21 days after the procedure.
We were alerted to this story by La Repubblica, and contacted by the son of the patient (who asked not to be named, for privacy reasons). He told us he found the study and asked the journal to retract it:
…I can say that it was absolutely devastating to realise that the pictures I was looking at were from the surgery that led to the death of my father. It is something that gives me a lot of sorrow thinking that the man in that picture with the open belly was him, when he was fighting for his life. I asked the rest of my family not to see them to avoid them the same shock.
Even before the retraction appeared, we received confirmation it was coming from Giuseppe Paolisso, the Principal of the School of Medicine at the Second University of Naples, where the authors are based: Continue reading Son sees dead father in case report, requests retraction
Sumitran-Holgersson already has one retraction under her belt — of a 2005 Blood paper, after another investigation concluded the results “cannot be considered reliable.” Sumitran-Holgersson and her husband, co-author Jan Holgersson, did not sign the retraction notice. Both were based at the Karolinska Institutet (KI) at the time, but have since moved to the University of Gothenburg.
Now, the University of Gothenburg has launched its own investigation of the papers questioned on PubPeer, according to Continue reading Biologist’s research under investigation in Sweden after being questioned on PubPeer
We can’t resist flagging some misleading language in a retraction note for a 2015 paper on the inner workings of an amoeba pathogen.
The note for “The Charms of the CHRM Receptors: Apoptotic and Amoebicidal effects of Dicyclomine on Acanthamoeba castellanii” is short, so we’re going to give it to you up front:
This accepted manuscript has been retracted because the journal is unable to verify reviewer identities.
Sounds like another case of faked emails to generate fake peer reviews, right? But that’s not what happened to this paper, according to the editor in chief of Antimicrobial Agents and Chemotherapy, Louis B. Rice, a professor at Brown University:
The number of papers retracted for fake peer reviews — well in excess of 100, by our count — continues to grow.
The latest to join the list are “Rebamipide plus proton pump inhibitor versus proton pump inhibitor alone in treatment of endoscopic submucosal dissection-induced gastric ulcer: a meta-analysis of randomized controlled trials” and “Association study of TGFBR2 and miR-518 gene polymorphisms with age at natural menopause, premature ovarian failure and early menopause among Chinese Han women,” both published in 2014 in Medicine.
Here’s how both notices, signed by senior publisher Duncan A. MacRae, read: Continue reading Fake peer review fells two more papers
A group of gastroenterology researchers in Italy has lost their 2010 paper in Internal and Emergency Medicine, the journal of the Italian Society of Internal Medicine, for plagiarizing and duplicate publication.
The article, “Gut microbiota and related diseases: clinical features,” was published as a supplement by a team from the University of Bologna. Its conclusions: Continue reading Mix-and-match text topples microbiome paper
After typing up 96 citations, researchers from the National Institute for Digestive Diseases, I.R.C.C.S. “S. de Bellis,” in Bari, Italy, apparently ran out of steam for the last five, earning themselves a retraction for plagiarism in a literature review of the effects of probiotics on intestinal cancer.
Here’s the notice for “Intestinal Microbiota, Probiotics and Human Gastrointestinal Cancers,” from the Journal of Gastrointestinal Cancer: Continue reading Yogurt to be kidding me: Five articles plagiarized in one retracted paper
The Journal of Evidence-Based Complementary Medicine (JEBCAM) has retracted a 2013 review on probiotics by an author from Turkey who patched the paper together from a variety of other sources — and then appears to have reused his own work elsewhere without attribution.
The article was written by Öner Özdemir, a pediatric allergy specialist at İstanbul Medeniyet University. According to the abstract: Continue reading Plagiarism spells demise of complementary medicine paper
A group of researchers from Italy has lost their 2010 paper in the Journal of Cellular Physiology for having plagiarized — in style.
The article, “Early Years of Biological Agents Therapy in Crohn’s Disease and Risk of the Human Polyomavirus JC Reactivation,” was led by Valeria Pietropaolo, of Sapienza University in Rome and the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University in Philadelphia.
The paper has been cited 10 times, according to Thomson Scientific’s Web of Knowledge. The abstract, which is still available, reads:
The American Journal of Gastroenterology has retracted a 2011 article on colon cancer by a group of Cleveland Clinic researchers after finding “evidence” of plagiarism in the text.
The article, a review, was titled “Molecular Pathways Underlying IBD-Associated Colorectal Neoplasia: Therapeutic Implications,” and has been cited 16 times, according to Thomson Scientific’s Web of Knowledge.